| Literature DB >> 31228176 |
Maria Molinos1, Fernando Dias Correia2, André Nogueira1, Ivo Magalhães1, Joana Guimarães1, Maria Moreira1, Isabel Barradas1, Laetitia Teixeira3,4,5, Joaquim Pires6, Rosmaninho Seabra6, Jorge Lains7, Virgílio Bento8.
Abstract
BACKGROUND: The demand for total hip arthroplasty (THA) is rising. In the face of rapidly increasing health care costs, ensuring widespread, cost-effective rehabilitation is a priority. Technologies allowing independent home-based rehabilitation may be the key to facilitate access, improve effectiveness, and lower costs of care.Entities:
Keywords: AI-powered rehabilitation; THA; THR; biofeedback; digital physiotherapy; motion trackers; telerehabilitation
Year: 2019 PMID: 31228176 PMCID: PMC6611148 DOI: 10.2196/14523
Source DB: PubMed Journal: JMIR Rehabil Assist Technol ISSN: 2369-2529
Figure 1System components. (A) Mobile app. Preparation screen (top left): this screen displays video and audio instructions for each exercise. Execution screen (bottom left). (B) Web portal. Prescription screen (top right) displaying the exercise list and session layout. Results screen (bottom right) presenting (1) date, time, and session duration; (2) pain and fatigue scores; and (3) information on each repetition-range of motion and movement errors.
Figure 2CONSORT (Consolidated Standards of Reporting Trials) diagram. PT: physiotherapy; THA: total hip arthroplasty.
Baseline characteristics of study participants (N=66).
| Population characteristics | Digital physiotherapy group (n=35) | Conventional rehabilitation (n=31) | ||
| Age (years), mean (SD) | 62.4 (8) | 66.6 (10) | .07a | |
| Gender (female), n (%) | 15 (43) | 16 (2) | .64 | |
| Operated hip side (right), n (%) | 16 (46) | 12 (39) | .74 | |
| Body mass index, mean (SD) | 28.3 (3) | 27.4 (4) | .31a | |
| Smoking, n (%) | 2 (6) | 7 (23) | .07b | |
| Hypertension, n (%) | 14 (40) | 12 (39) | >.99 | |
| Diabetes, n (%) | 11 (31) | 7 (23) | .59 | |
| Pulmonary disease, n (%) | 1 (3) | 1 (3) | >.99 | |
| Cardiac disease, n (%) | 3 (9) | 5 (16) | .46b | |
| Stroke, n (%) | 1 (3) | 0.0 | —c | |
| Renal disease, n (%) | 0.0 | 0.0 | — | |
| Bleeding disorders, n (%) | 0.0 | 2 (6) | — | |
| ASAd (class 3 or 4), n (%) | 8 (23) | 10 (32) | .56 | |
| Steroids for chronic condition, n (%) | 0 | 0 | — | |
| Previous contralateral hip replacement, n (%) | 7 (20) | 5 (16) | .93 | |
| Previous knee replacement, n (%) | 1 (3) | 0 | — | |
| Time between admission and surgery (hours) | <24 | <24 | — | |
| Operative time (min), mean (SD) | 63.7 (19) | 59.9 (9) | .10a | |
| Noncemented prosthesis, n (%) | 2 (6) | 2 (6) | >.99 | |
| Minor adverse events before discharge, n (%) | 0.0 | 0.0 | — | |
| Length of stay (days), median (IQRe) | 6.0 (2) | 6.0 (1) | .43f | |
aIndependent sample t test.
bFisher exact test.
cNot applicable.
dAmerican Society of Anesthesiology physical status classification system.
eIQR: interquartile range.
fMann-Whitney U test.
Primary outcome assessment of Timed Up and Go (TUG) test: intention-to-treat analysis (N=66).
| Time point | TUG time (seconds), median (IQRa) | Estimate difference between groups (95% CI) | |||
| Digital PTc group (n=35) | Control group (n=31) | ||||
| Baseline | 17.50 (6.33) | 14.89 (9.42) | .12 | 2.34 (−0.69, 5.17) | |
| 8 weeks | 7.26 (2.15) | 11.03 (6.84) | <.001 | −3.34 (−5.14, −1.70) | |
| Change baseline-8 weeks | −10.50 (7.45) | −2.90 (7.10) | <.001 | −6.33 (−8.79, −3.42) | |
| 6 months | 6.38 (2.30) | 8.20 (4.22) | <.001 | −1.87 (−3.02, −0.62) | |
| Change baseline-6 months | −10.50 (7.39) | −5.10 (6.94) | .005 | −4.79 (−7.24, −1.71) | |
aIQR: interquartile range.
bMann-Whitney U test.
cPT: physiotherapy.
Secondary outcome of hip range of motion assessment: intention-to-treat analysis (N=66).
| Time point and variable | Median (IQRa) | Estimate difference between groups (95% CI) | |||
| Digital PTc group (n=35) | Control group (n=31) | ||||
| Lying flexion | 28.2 (19.1) | 37.1 (20.0) | .07 | −8.9 (−18.53, 0.67) | |
| Lying abduction | 12.2 (5.4) | 15.9 (9.1) | .05 | −3.7 (−7.48, 0.02) | |
| Standing flexion | 45.1 (15.9) | 49.6 (16.7) | .27 | −4.5 (−12.52, 3.53) | |
| Standing hyperextension | −11.9 (7.0) | −15.4 (8.8) | .31 | 3.4 (−0.44, 7.33) | |
| Standing abduction | 23.5 (6.8) | 25.8 (10.7) | .08 | −2.2 (−6.78, 2.26) | |
| Lying flexion | 84.0 (23.5) | 66.6 (19.6) | .002 | 17.5 (6.78, 28.18) | |
| Lying abduction | 50.5 (17.5) | 39.2 (15.2) | .01 | 11.4 (3.27:19.50) | |
| Standing flexion | 87.6 (21.2) | 80.0 (19.8) | .14 | 7.5 (−2.58, 17.66) | |
| Standing hyperextension | −36.7 (14.3) | −30.1 (8.2) | .03 | −6.6 (−12.28, −0.96) | |
| Standing abduction | 52.2 (13.8) | 40.3 (11.3) | <.001 | 11.9 (5.62, 18.13) | |
| Lying flexion | 55.8 (27.4) | 29.4 (25.6) | <.001 | 26.4 (13.32, 39.50) | |
| Lying abduction | 38.4 (17.3) | 23.3 (15.7) | <.001 | 15.1 (6.91, 23.25) | |
| Standing flexion | 42.5 (21.3) | 30.4 (20.3) | .02 | 12.0 (1.81, 22.33) | |
| Standing hyperextension | −24.7 (12.7) | −14.7 (10.1) | .001 | −10.1 (−15.75, −4.38) | |
| Standing abduction | 28.7 (13.4) | 14.6 (13.5) | <.001 | 14.1 (7.51, 20.76) | |
| Lying flexion | 80.7 (24.4) | 70.0 (19.3) | .06 | 10.7 (−0.27, 21.6) | |
| Lying abduction | 49.8 (18.2) | 41.6 (14.3) | .048 | 8.2 (0.06, 16.31) | |
| Standing flexion | 90.2 (23. 1) | 84.8 (19.8) | .32 | 5.4 (−5.25, 16.03) | |
| Standing hyperextension | −34.1 (15.1) | −28.8 (9.2) | .10 | −5.3 (−11.36, 0.81) | |
| Standing abduction | 51.7 (15.1) | 43.8 (11.8) | .02 | 8.0 (1.24, 14.69) | |
| Lying flexion | 52.5 (26.6) | 32.8 (25.6) | .003 | 19.6 (6.73, 32.50) | |
| Lying abduction | 37.6 (18.2) | 25.7 (15.2) | .01 | 11.9 (3.57, 20.20) | |
| Standing flexion | 45.1 (22.6) | 35.2 (20.6) | .07 | 9.9 (−0.79, 20.57) | |
| Standing hyperextension | −22.2 (13.3) | −13.5 (11.1) | .01 | −8.7 (−14.72, −2.59) | |
| Standing abduction | 28.2 (14.3) | 18.0 (12.1) | .003 | 10.2 (3.64, 16.74) | |
aIQR: interquartile range.
bMann-Whitney U test.
cPT: physiotherapy.
Secondary outcome of patient-reported Hip dysfunction and Osteoarthritis Outcome Scale (HOOS): intention-to-treat analysis (N=66).
| Time point and variable | Score, median (IQRa) | Estimate difference between groups (95% CI) | |||
| Digital PTc group (n=35) | Control group (n=31) | ||||
| Symptoms | 35.0 (20.0) | 40.0 (30.0) | .12 | −10.0 (−20.0, 0.0) | |
| Pain | 33.0 (13.0) | 33.0 (35.0) | .50 | −3.0 (−13.0, 5.0) | |
| Activities of daily living | 29.0 (15.0) | 28.0 (28.0) | .75 | 1.0 (−6.0, 7.0) | |
| Sports | 0.0 (6.0) | 0.0 (19.0) | .34 | 0.0 (0.0, 0.0) | |
| Quality of life | 13.0 (13.0) | 19.0 (25.0) | .03 | −6.0 (−13.0, 0.0) | |
| Symptoms | 100.0 (5.0) | 95.0 (20.0) | .01 | 5.00 (0.0, 10.0) | |
| Pain | 100.0 (7.0) | 98.0 (12.0) | .24 | 0.0 (0.0, 5.0) | |
| Activities of daily living | 93.0 (11.0) | 82.0 (14.0) | <.001 | 9.0 (4.0, 13.0) | |
| Sports | 50.0 (18.0) | 38.0 (19.0) | .004 | 12.0 (6.0, 19.0) | |
| Quality of life | 81.0 (19.0) | 69.0 (31.0) | .08 | 6.0 (0.0, 18.0) | |
| Symptoms | 60.0 (30.0) | 45.0 (30.0) | .06 | 10.0 (0.0, 20.0) | |
| Pain | 60.0 (22.0) | 60.0 (32.0) | .75 | 2.0 (−10.0, 10.0) | |
| Activities of daily living | 56.0 (23.0) | 57.0 (27.0) | .63 | −2.0 (−10.0, 6.0) | |
| Sports | 44.0 (25.0) | 38.0 (25.0) | .26 | 6.0 (−6.0, 13.0) | |
| Quality of life | 63.0 (31.0) | 50.0 (25.0) | .46 | 6.0 (−6.0, 13.0) | |
| Symptoms | 100.0 (5.0) | 95.0 (10.0) | .20 | 0.0 (0.0, 5.0) | |
| Pain | 100.0 (5.0) | 100.0 (7.0) | .75 | 0.0 (0.0, 0.0) | |
| Activities of daily living | 96.0 (11.0) | 88.0 (19.0) | .02 | 4.0 (0.0, 10.0) | |
| Sports | 75.0 (32.0) | 50.0 (32.0) | .01 | 19.0 (6.0, 37.0) | |
| Quality of life | 94.0 (12.0) | 81.0 (19.0) | .02 | 7.0 (0.0, 19.0) | |
| Symptoms | 60.0 (25.0) | 45.0 (30.0) | .06 | 10.0 (0.0, 20.0) | |
| Pain | 65.0 (18.0) | 53.0 (30.0) | .21 | 7.0 (−5.0, 17.0) | |
| Activities of daily living | 63.0 (22.0) | 56.0 (25.0) | .10 | 7.0 (−1.0, 15.0) | |
| Sports | 69.0 (31.0) | 38.0 (38.0) | .004 | 25.0 (7.0, 37.0) | |
| Quality of life | 75.0 (32.0) | 56.0 (31.0) | .01 | 19.0 (6.0, 25.0) | |
aIQR: interquartile range.
bMann-Whitney U test.
cPT: physiotherapy.
Outcomes assessment: repeated measures analysis.
| Outcome variable | Time | Group | Time*Group | ||||
| Timed Up and Goa,b | 128.6 (2.5,159.6) | <.001 | 12.3 (1,64) | .01 | 14.9 (3.2,159.6) | <.001 | |
| Lying hip flexion | 119.4 (1.9,121.6) | <.001 | 6.5 (1,64) | .01 | 12.0 (1.9,121.6) | <.001 | |
| Lying hip abduction | 139.0 (2.9,188.1) | <.001 | 9.4 (1,64) | .03 | 10.4 (2.9,121.6) | <.001 | |
| Standing hip flexion | 154.9 (1.9,123.1) | <.001 | 1.06 (1,64) | .31 | 4.0 (1.9,123.1) | .02 | |
| Standing hip hyperextension | 91.1 (3.3,211.2) | <.001 | 4.6 (1,64) | .04 | 8.2 (3.3,211.2) | <.001 | |
| Standing hip abduction | 125.5 (2.1,137.3) | <.001 | 10.0 (1,64) | .002 | 12.1 (2.1,137.3) | <.001 | |
aln transformation.
bGreenhouse-Geisser correction.
Figure 3Evolution of the outcomes over time in both groups based on the repeated measures analysis (estimated marginal means are presented). (A) Timed Up and Go (TUG) score, (B) lying hip flexion, (C) lying hip abduction, (D) standing hip flexion, (E) standing hip hyperextension, (F) standing hip abduction. PT: physiotherapy.